SIRT1 and breast cancer: Recent research studies showed that PTS-catechol (4) appears to contribute stronger biological activities than PTS (2) in human breast cancer cells [31], and possesses anti-adipogenic, anti-inflammatory, anti-oxidant, and sirtuin 1 (Sirt-1) inhibitory activities [32].